abstract |
The present invention relates to compounds of formula (IA) as well as the pharmaceutically acceptable salts thereof. ≪ EMI ID = Wherein R 1a , R 1b , X, R 2a , R 2b , W, R 3 , R 4 and R 5 are as defined herein. The compound has been shown to function as a MEK inhibitor which may be useful in the treatment of hyperproliferative diseases such as cancer and inflammation. |